Benchling Stock

benchling.comHealthcare / Healthcare softwareFounded: 2012Funding to Date: $424.97MM

Benchling, founded in 2012, is the developer of a biotech platform for biology researchers and research organizations. The cloud-based R&D platform is designed to be an “all-in-one experiment, sample, process, and lab management system”, aiming to make research more accessible, while enabling researchers and scientists to be more collaborative.

Register To Buy and Sell Shares

For more details on financing and valuation for Benchling, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Benchling’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Benchling.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Sajith Wickramasekara
Co-Founder & Chief Executive Officer
Ashutosh Singhal
Co-Founder & President
Richard Wong
Chief Financial Officer
Stephen Deasy
Chief Technology Officer
Zach Powers
Chief Information Security Officer
Lindsey Irvine
Chief Marketing Officer
Niall Wall
Chief Partner Officer & Head of Partners
Shawna Wolverton
Chief Product Officer

Board Members

Miles Grimshaw
Thrive Capital
Eric Vishria
Benchmark
William Griffith
ICONIQ Growth

Frequently Asked Questions About Benchling’s Stock

plusminus
Can you buy Benchling’s stock?
Benchling is not publicly traded on NYSE or NASDAQ in the U.S. To buy Benchling’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Benchling’s stock?
Yes, you can sell stock of a private company like Benchling. Forge can help you sell your Benchling stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Benchling’s stock price?
Benchling is a privately held company and therefore does not have a public stock price. However, you may access Benchling’s private market stock price with Forge Data.
plusminus
What is Benchling’s stock ticker symbol?
Benchling does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Benchling’s ERGs Offer ‘A Passport for Continuous Improvement’
When Roni McGee became Benchling’s diversity, equity and inclusion lead in 2021, she knew she wanted to begin transforming the company’s employee resource groups from affinity groups to robust and structured communities that could offer meaningful support for colleagues across the company.
Benchling Delivers an Integrated R&D Ecosystem with New Product Offerings
Benchling, the R&D Cloud powering the biotechnology industry, today launched new integrations and features that connect data and analytics tools directly in Benchling with just a few clicks, providing scientists with a connected platform to make faster decisions and generate better insights.
Benchling Launches Partner Program with Ecosystem of Global Services Partners
Benchling, the R&D Cloud powering the biotechnology industry, today launched its Benchling Partner Program, bringing a best-in-class, R&D partner ecosystem to biotech customers.
Updated on: Apr 14, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.